Ppt_Ankit_Medicaid
-
Upload
ankit-raheja -
Category
Documents
-
view
18 -
download
2
Transcript of Ppt_Ankit_Medicaid
![Page 1: Ppt_Ankit_Medicaid](https://reader035.fdocuments.net/reader035/viewer/2022062420/55c412b2bb61eb8a1c8b47fb/html5/thumbnails/1.jpg)
Medicaid Expansion AnalysisBy
Ankit Raheja
Medicaid Expansion AnalysisBy
Ankit Raheja
![Page 2: Ppt_Ankit_Medicaid](https://reader035.fdocuments.net/reader035/viewer/2022062420/55c412b2bb61eb8a1c8b47fb/html5/thumbnails/2.jpg)
Agenda
The rationale for Medicaid Expansion
Opportunities, Risk, and Mitigation
This is an example text. Go ahead and replace it
Impact on Stakeholders of Healthcare Industry
The changes in the Medicaid program
Effect of Medicaid Expansion on Pharmaceutical Industry
11
22
33
44
55
66
77
Medicaid Expansion funding
Opportunities for the Consulting Industry 77
![Page 3: Ppt_Ankit_Medicaid](https://reader035.fdocuments.net/reader035/viewer/2022062420/55c412b2bb61eb8a1c8b47fb/html5/thumbnails/3.jpg)
Key Details About Medicaid•Jointly funded and administered by Federal government and States •Largest source of funding for medical and health-related services for 60M limited-income individuals- 16.6% of spending in healthcare in the USA
Rationale for Medicaid Expansion
The Rationale for Medicaid Expansion
Medicaid Expansion will reduce the number of uninsured in USA by 48%
![Page 4: Ppt_Ankit_Medicaid](https://reader035.fdocuments.net/reader035/viewer/2022062420/55c412b2bb61eb8a1c8b47fb/html5/thumbnails/4.jpg)
• The ACA called for nationwide expansion of Medicaid eligibility• Upheld by Supreme Court but not allowed to force states to adopt and
not allowed to take away the existing Medicaid funding• Jan 2014, Medicaid will increase eligibility limits for adults to 133% of
FPL - $14,856 for one person , $30,675 for a family of four• The CBO estimates 11 Million Americans will gain coverage by 2022• Funding mostly by Fed over 2013-2022 . Saving for States by $10
Billion
What is Medicaid Expansion Program?
In Billion Dollars
![Page 5: Ppt_Ankit_Medicaid](https://reader035.fdocuments.net/reader035/viewer/2022062420/55c412b2bb61eb8a1c8b47fb/html5/thumbnails/5.jpg)
Changing Nature of Medicaid
• Medicaid Expansion for the newly eligible will be funded mostly by Fed and the Fed Share will be set at 90 % from 2020. Currently Fed
sponsors 60%
• Newly Eligible Medicaid Population will be unmarried , have median age of 31 , and will have median income of $7261 for a single individual
![Page 6: Ppt_Ankit_Medicaid](https://reader035.fdocuments.net/reader035/viewer/2022062420/55c412b2bb61eb8a1c8b47fb/html5/thumbnails/6.jpg)
Other Changes in Medicaid…
Changes from existing Medicaid
Expanded to include newly eligible , who have income below 133 % FPL and changes to category of children , pregnant women and families
MAGI Methodology will be used to determine eligibility for “newly eligible” using Health Benefit Exchange web portal
States to cover smoking cessation programs and fiscal incentive to cover prevention service without enrollees paying any cost sharing
Creation of Centre of Medicare and Medicaid Innovations to test new payment and healthcare delivery models
![Page 7: Ppt_Ankit_Medicaid](https://reader035.fdocuments.net/reader035/viewer/2022062420/55c412b2bb61eb8a1c8b47fb/html5/thumbnails/7.jpg)
Medical Expansion Funding
• Fed would be funding most of the expansion 92% , while the remaining 8% funded by State
• Over the 2013 to 2022 period, an additional $781 billion will be spent on newly eligible
• Under the Medicaid Expansion Act, reduced spending on uncompensated care and net saving of over 10 billion dollars for State
In Billion Dollars
![Page 8: Ppt_Ankit_Medicaid](https://reader035.fdocuments.net/reader035/viewer/2022062420/55c412b2bb61eb8a1c8b47fb/html5/thumbnails/8.jpg)
Unique Opportunities and Risks for Pharmaceutical Industry
New Market entry Strategy•Changing Customer Demographic•New capability development •New Sales Force and Marketing Strategy , Stronger Value Proposition•Increase in number of people with chronic condition under Medicaid expansionReduction in Payer Profitability and pass through to Pharmaceutical Companies•Pharmaceutical Companies need to communicate the efficacy of their drugsStrong Fed and State Power•Medicaid expansion is funded by Fed so existing models of lobbying may changeHealthcare Data Explosion•Increased number of people , digitalization , accountability will provide unique opportunity to analyze terabytes of data and provide competitive edgeNew Fees•IRS now imposes an annual fee on manufacturers and importers of branded drugs:•Excise tax on pharmaceutical companies based on market share – $ 2.5 billion
pro
ducts
![Page 9: Ppt_Ankit_Medicaid](https://reader035.fdocuments.net/reader035/viewer/2022062420/55c412b2bb61eb8a1c8b47fb/html5/thumbnails/9.jpg)
Quantifying the Benefits
Number of newly eligible : 20 MillionAverage spent on drugs per year : 333$Pre 2014 rebate : 15% on AMPPost 2014 rebate : 23% on AMPNew spend on drugs : 333*(1- 23%)/(1-15%) = 302 Net Benefits
20 Million20 Million $302$302 $ 60 Billion
A 60 Billion Dollar OpportunityA 60 Billion Dollar Opportunity
![Page 10: Ppt_Ankit_Medicaid](https://reader035.fdocuments.net/reader035/viewer/2022062420/55c412b2bb61eb8a1c8b47fb/html5/thumbnails/10.jpg)
Opportunities for Healthcare ConsultingFirms for Pharmaceutical Industry
• Healthcare reform strategy development/deployment
• Medicaid expansion segmentation / targeting / positioning strategy
• Healthcare Analytics
• Statewide cost benefit analysis of Medicaid
• Marketing and Sales force strategy
• AMP , Rebate % determination strategy
![Page 11: Ppt_Ankit_Medicaid](https://reader035.fdocuments.net/reader035/viewer/2022062420/55c412b2bb61eb8a1c8b47fb/html5/thumbnails/11.jpg)
THANK YOU!
Your Logo